Fetal dose from radiotherapy with photon beams: report of AAPM Radiation Therapy Committee Task Group No. 36.
Approximately 4000 women per year in the United States require radiotherapy during pregnancy. This report presents data and techniques that allow the medical physicist to estimate the radiation dose the fetus will receive and to reduce this dose with appropriate shielding. Out-of-beam data are presented for a variety of photon beams, including cobalt-60 gamma rays and x rays from 4 to 18 MV. Designs for simple and inexpensive to more complex and expensive types of shielding equipment are described. Clinical examples show that proper shielding can reduce the radiation dose to the fetus by 50%. In addition, a review of the biological aspects of irradiation enables estimates of the risks of lethality, growth retardation, mental retardation, malformation, sterility, cancer induction, and genetic defects to the fetus.
Stovall
M
M
Department of Radiation Physics, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Blackwell
C R
CR
Cundiff
J
J
Novack
D H
DH
Palta
J R
JR
Wagner
L K
LK
Webster
E W
EW
Shalek
R J
RJ
D005260:Female; D005333:Fetus / Q000528:radiation effects*; D005865:Gestational Age; D006801:Humans; D017785:Photons; D011247:Pregnancy / Q000528:radiation effects*; D011829:Radiation Dosage; D011832:Radiation Injuries / Q000517:prevention & control; D011835:Radiation Protection / Q000295:instrumentation*; D011878:Radiotherapy / Q000009:adverse effects / Q000379:methods*